Article

Dr. Pomerance: How the mix of medicine and surgery attracted him to ophthalmology

Tennessee Academy of Ophthalmology’s doctor of the month shares what excites him about ophthalmology, his biggest career challenge, and chocolate as his favorite comfort food.

Dr. Pomerance: How the great mix of medicine and surgery attracted him to ophthalmology

Pomerance

When and why did you decide to pursue ophthalmology?

While in training for General Surgery at Walter Reed Army Medical Center, I was assigned to the Ophthalmology Department for a rotation. I was immediately attracted to ophthalmology because of the great mix of medicine and surgery. The eye is often the window to the rest of the body and ophthalmologists are often called to assist in the diagnosis of medical conditions unrelated to the eye. Often a routine exam of the eye leads us to a diagnosis that would remain otherwise obscure.

The surgical aspects of this specialty are truly dynamic and unique. During my career, there have been quantum leaps in technology and surgeon capability in ophthalmology. It continues to be exciting for me to go to work every day, since there are always new challenges and new treatments to combat vision loss.

For more of this Q&A with Dr. Pomerance, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
© 2025 MJH Life Sciences

All rights reserved.